Ignite Creation Date:
2024-05-06 @ 7:15 AM
Last Modification Date:
2024-10-26 @ 11:46 AM
Study NCT ID:
NCT02500550
Status:
COMPLETED
Last Update Posted:
2021-05-18
First Post:
2015-07-14
Brief Title:
Safety and Efficacy of Two Doses of ATIR101 a T-lymphocyte Enriched Leukocyte Preparation Depleted of Host Alloreactive T-cells in Patients With a Hematologic Malignancy Who Received a Hematopoietic Stem Cell Transplantation From a Haploidentical Donor
Sponsor:
Kiadis Pharma
Organization:
Kiadis Pharma
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Myelodysplastic Syndrome |
| Acute Myeloid Leukemia |
| Acute Lymphoblastic Leukemia |